U.S. Markets closed

Protalix: 1Q Earnings Snapshot

CARMIEL, Israel (AP) _ Protalix BioTherapeutics Inc. (PLX) on Wednesday reported a loss of $9.4 million in its first quarter.

The Carmiel, Israel-based company said it had a loss of 6 cents per share.

The drug developer posted revenue of $4.6 million in the period.

The company's shares closed at 40 cents. A year ago, they were trading at 92 cents.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX